MMP-9 and TIMP-1 in the cord blood of premature infants developing BPD

Area of Science:

• Neonatology
• Pulmonology
• Biochemistry

Background:

• Bronchopulmonary dysplasia (BPD) is a significant complication in premature infants.
• Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play roles in tissue remodeling and inflammation.
• MMP-9 and TIMP-1 are implicated in lung injury and development.

Purpose of the Study:

• To investigate the association between cord blood levels of MMP-9 and TIMP-1 and the development and severity of BPD in extremely premature infants.
• To explore the relationship between MMP-9/TIMP-1 ratios and BPD severity.
• To examine correlations between MMP-9, TIMP-1, and maternal chorioamnionitis.

Main Methods:

• ELISA was used to quantify MMP-9 and TIMP-1 levels in cord blood samples from 29 premature infants (<30 weeks gestation).
• Infants were categorized based on BPD development (severe, moderate, mild, or none).
• Statistical analyses, including multivariate linear regression, were performed to assess correlations.

Main Results:

• MMP-9/TIMP-1 ratios were significantly higher in infants who developed severe or moderate BPD compared to those with mild or no BPD (P = 0.015).
• MMP-9 levels and MMP-9/TIMP-1 ratios positively correlated with the duration of oxygen supplementation.
• Both MMP-9 levels and MMP-9/TIMP-1 ratios showed a correlation with the severity of maternal chorioamnionitis.

Conclusions:

• Elevated cord blood MMP-9 and MMP-9/TIMP-1 ratios may be linked to the pathogenesis and severity of BPD in premature infants.
• These biomarkers might also be associated with maternal chorioamnionitis, suggesting a potential role in adverse neonatal outcomes.
• Further research is warranted to elucidate the precise mechanisms and clinical implications.